Condition: Obsessive-Compulsive Disorder · Illness Anxiety Disorder · Body Dysmorphic Disorders · Sponsor: Stanford University
The purpose of the study is to assess the tolerability and efficacy of dextromethorphan in combination with fluoxetine for symptom relief in OCD and related disorders.
This description comes directly from the study's public registry record.
Alessa Gaeta, BA · 650 497 2578 · ocdresearch@stanford.edu
Always discuss trial participation with your own doctor first.
| Stanford University | Stanford, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04899687